Bookmark and Share

Iran Sanctions Result In Shortages of Cancer Drugs, Heart Medicine


By Golnaz Esfandiari, RFE/RL

Iran's "Shargh" daily reports that the country is facing shortages of drugs for the treatment of 30 illnesses including cancer, heart and breathing problems, Thalassemia and multiple sclerosis (MS).

Drugs for cancer, heart problems, and several other ailments are now in short supply in Iran.
(file photo)

According to the daily, the shortage is the result of international sanctions against the Islamic republic, the implementation of subsidy cuts, and the foreign-currency exchange-rate fluctuations that Iran has experienced in recent months.

Shargh has issued a list of the medications that are difficult to obtain

"Shargh" reports that the production and import of drugs for cancer and other diseases has reached "worrying levels."

The daily has issued a list of the anticancer drugs and other medications that are difficult to obtain, including drugs that are used in chemotherapy such as Fluoroucil and Doxorucibin.

Copyright (c) 2012 RFE/RL, Inc. Reprinted with the permission of Radio Free Europe/Radio Liberty, 1201 Connecticut Ave., N.W. Washington DC 20036.

© Copyright 2012 (All Rights Reserved)